Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 9 Lung Neoplasms 6 Carcinoma, Non-Small-Cell Lung 4 Prostatic Neoplasms 3 Barrett Esophagus 3 Stomach Neoplasms 2 Recurrence 2 Rectal Neoplasms 2 Pancreatic Neoplasms 2 Neoplasms 2 Multiple Pulmonary Nodules 2 Melanoma 2 Glioma 2 Colorectal Neoplasms 2 Adenocarcinoma of Lung 2 Triple Negative Breast Neoplasms 1 Thyroid Nodule 1 Thyroid Neoplasms 1 Spinal Fractures 1 Solitary Pulmonary Nodule 1 Smoking Cessation 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Phyllodes Tumor 1 Osteoporosis 1 Nevus 1 Neoplastic Cells, Circulating 1 Neoplasm Metastasis 1 Lymphoma, Follicular 1 Lung Diseases 1

Interventions

Ibandronic Acid 8 Gemcitabine 8 Doxorubicin 6 Cyclophosphamide 6 Zoledronic Acid 5 Radiation 4 Nivolumab 4 Irinotecan 4 pembrolizumab 3 Vincristine 3 Temozolomide 3 Magnetic Resonance Spectroscopy 3 Ipilimumab 3 Docetaxel 3 Denosumab 3 Cisplatin 3 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 3 regorafenib 2 pegfilgrastim 2 Tranexamic Acid 2 Trabectedin 2 Surveys and Questionnaires 2 Sunitinib 2 Standard of Care 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy 2 Radiosurgery 2 Quality of Life 2 Proton Therapy 2 Observation 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Bone Neoplasms × Diagnostic Imaging × Clear all

NCT04884048 2023-06-06

BTI-RADS M

Central Hospital, Nancy, France

Bone Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡